Potential mechanisms of interferon-alpha induced autoimmunity.
about
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic AnemiaInterferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: A case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy.Aplastic anemia associated with interferon alpha 2a in a patient with chronic hepatitis C virus infection: a case report.Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature.Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles.Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain ControGenetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.Neurological complications of hepatitis C infection.Kaleidoscope of autoimmune diseases in HIV infection.Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.Occult hepatitis C virus infection in patients with autoimmune hepatitis.Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.Postinfectious immunodeficiency and autoimmunity: pathogenic and clinical values and implications.Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case.
P2860
Q28071495-7719812E-BD20-4853-8899-B59E83AD1B47Q33734946-EB6712BE-DAB8-4CA2-97C5-AFC134540EB3Q34078325-2784920A-18F7-4A43-AA36-38BCE487B85AQ34145669-F5A633CF-F99F-43B3-B998-E4659B03D9BFQ34606147-7189F1D2-B3F5-443F-9778-1F11B1BF1BD0Q35028863-F5A75C78-75B0-40DD-BA7D-676C6D6D96F9Q36512352-22AB0437-01B2-4E20-836A-FF6C263BDE2EQ36556219-9EABC8B0-F97F-4EEA-862F-618EBBF8083DQ36841724-9CAFC956-D63E-449C-9ECD-D53FCCD705DFQ38044680-390854F9-04B8-4022-AE2B-1F9B00C578DCQ38932786-70BFF5DF-53E6-40B0-971A-331D4B71CCD8Q39130785-847AF891-863D-45BC-A90E-15FC65D8F22CQ40293670-2B6AB843-5328-4AB1-B73F-3ACE6E527ADAQ41692201-BCD5D17C-5027-42F6-AFF9-FC3F64CE1B88Q42977642-1DF7D4F6-B77F-4A4A-9DB2-A81E7EF9BFB4Q43944431-B50E98D1-241D-4D95-B6F1-9D48DC586775Q44234056-B8DAF230-4DDB-4960-AF2C-ACA60A35B865Q48296904-FE4291F9-4775-493F-8212-6F39230D576FQ50555761-B3322CE7-FB9C-439F-AE65-90FB853981AF
P2860
Potential mechanisms of interferon-alpha induced autoimmunity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Potential mechanisms of interferon-alpha induced autoimmunity.
@ast
Potential mechanisms of interferon-alpha induced autoimmunity.
@en
type
label
Potential mechanisms of interferon-alpha induced autoimmunity.
@ast
Potential mechanisms of interferon-alpha induced autoimmunity.
@en
prefLabel
Potential mechanisms of interferon-alpha induced autoimmunity.
@ast
Potential mechanisms of interferon-alpha induced autoimmunity.
@en
P2860
P1433
P1476
Potential mechanisms of interferon-alpha induced autoimmunity.
@en
P2093
Bernard Conrad
P2860
P304
P356
10.1080/08916930310001602137
P577
2003-12-01T00:00:00Z